Beta · prototype— This site is under construction: rankings, texts and features change every week.

Assort Health

Active#4 worldwide · Appointment booking

Appointment booking

HQUnited States
Last roundEquity round · Jun 2026

Uback rankings

How the AI ranks →
RankingTierRankEditionNext update
Appointment booking · worldwideTop 9#4Edition 0 (beta) · Sep 202618 Jan 2027
Rank historySep 2026 · #4 Appointment bookingFirst edition: no movements yet.

Estimated valuation

AI · Appointment booking ranking (worldwide)
≈ USD 1.2bnUSD 1–1.6bn · Unicorn High confidence
Anchor
Last known equity round: Equity round · USD 120M · Jun 2026
Published valuation
USD 1.2bn · Jun 2026

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Funding history

DateRoundAmountTypeInvestorsSource
Jun 2026Equity roundUSD 120MEquityMenlo Ventures, Lightspeedforbes.com

Rounds as cited by Uback’s rankings and their sources. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Assort Health as a PDF, on one of three angles only:

ValuationWhat is Assort Health worth?
Versus competitorsHow does it compare?
Who should acquire itStrategic buyers, and why
Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication and never change the rank.

Comparable companies in appointment booking

Full appointment booking ranking →

Investors in Assort Health: Menlo Ventures · Lightspeed

Sources. forbes.com · mobihealthnews.com · fiercehealthcare.com

Last updated: Sep 2026Report an error

Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.